NCT01670045View on ClinicalTrials.gov

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tocilizumab

Tocilizumab in accordance with the licensed label recommendation.

Trial Locations (9)

10430

Central Jakarta

20157

Medan

40161

Bandung

65111

Malang

76121

Balikpapan

95115

Manado

Unknown

Central Java

Denpasar

Jakarta

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01670045 - A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter